|
Index of reports
> Life Threatening Events (220)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Carboplatin life threatening events. The selected reports were submitted to the FDA during the sample period of about a year. Reports 1 - 30 of 220 Next >>
Possible Carboplatin side effects in female
Reported by a pharmacist from United States on 2012-08-24
Patient: female, weighing 139.7 kg (307.3 pounds)
Reactions: Glossodynia, Unresponsive To Stimuli, Hypoxia
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Carboplatin
Other drugs received by patient: Lorazepam; Warfarin Sodium; Nifedipine; Citalopram Hydrobromide; Fiornal; Joint Food; Tylox; Losartan Potassium; Omeprazole; Paclitaxel; Calcium D3; Dexamethasone
Possible Carboplatin side effects in 59 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-23
Patient: 59 year old female
Reactions: Encephalopathy
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Carboplatin
Start date: 2012-07-20
End date: 2012-07-20
Etoposide
Start date: 2012-07-19
End date: 2012-07-21
Ifosfamide
Start date: 2012-07-20
End date: 2012-07-21
Mabthera
Start date: 2012-07-19
End date: 2012-07-19
Mesna
Start date: 2012-07-20
End date: 2012-07-21
Other drugs received by patient: Solu-Medrol; Acetaminophen; Polaramine
Possible Carboplatin side effects in 62 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-22
Patient: 62 year old female
Reactions: Appendicitis
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: 1df: 4auc on day 1 of each 21 day cycle
Indication: Neoplasm
Start date: 2012-03-21
Gemcitabine Hydrochloride
Dosage: 12jun12 end of cycle 4, day 1 and 8 of each 21 day cycle
Indication: Neoplasm
Start date: 2012-04-11
Other drugs received by patient: Alprazolam; Sodium Chloride; Dexamethasone; Acetaminophen; Ondansetron; Pegfilgrastim; Prochlorperazine Edisylate; Aprepitant; Omega 3 Fatty Acid; Ergocalciferol; Esomeprazole Sodium; Docusate Sodium; Hydrocortisone; Lorazepam; Acetaminophen; Pepcid; Aprepitant; Heparin; Benadryl; Prochlorperazine Edisylate; Hydrocortisone Sodium Succinate; Multi-Vitamin; Levothyroxine Sodium; Omeprazole; Pegfilgrastim
Possible Carboplatin side effects in
Reported by a consumer/non-health professional from Singapore on 2012-08-22
Patient:
Reactions: Incorrect Route of Drug Administration, Myalgia, Tumour Lysis Syndrome, Rhabdomyolysis, Demyelination
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Etoposide
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Ifosfamide
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Rituximab
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Velcade
Dosage: unk mg/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Velcade
Dosage: unk
Start date: 2012-07-31
Other drugs received by patient: Methotrexate; Lamivudine; Acyclovir; Pentamidine; Omeprazole
Possible Carboplatin side effects in 54 year old female
Reported by a physician from United States on 2012-08-21
Patient: 54 year old female, weighing 68.0 kg (149.6 pounds)
Reactions: White Blood Cell Count Decreased, Anaemia, Febrile Neutropenia, Pancytopenia, Platelet Count Decreased, Device Related Infection, Neutrophil Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: 10 mg/kg, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Carboplatin
Dosage: 6 df, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Cyclophosphamide
Dosage: 600 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-10
Doxorubicin HCL
Dosage: 60 mg/m2, unk
Indication: Breast Cancer
Start date: 2011-11-10
Paclitaxel
Dosage: 80 mg/m2, per chemo regim
Indication: Breast Cancer
Start date: 2011-08-11
Pegfilgrastim
Dosage: 480 mug, unk
Indication: Chemotherapy
Start date: 2011-12-22
Other drugs received by patient: Tylenol (Caplet); Emend; Levaquin; Decadron; Zofran / 00955302 /; Aloxi; Compazine
Possible Carboplatin side effects in 65 year old female
Reported by a physician from Switzerland on 2012-08-21
Patient: 65 year old female
Reactions: Vomiting, Diarrhoea, Anaemia, General Physical Health Deterioration, Hypokalaemia
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Avastin
Dosage: date of last dose prior to sae: 20/jan/2012
Indication: Adenocarcinoma
Start date: 2011-12-30
Carboplatin
Indication: Adenocarcinoma
Start date: 2011-02-14
Cisplatin
Dosage: date of last dose prior to sae: 20/jan/2012
Indication: Adenocarcinoma
Start date: 2011-12-30
Pemetrexed Disodium
Dosage: date of last dose prior to sae: 20/jan/2012
Indication: Adenocarcinoma
Start date: 2011-12-30
Other drugs received by patient: Crestor; Dolpasse; Potassium Chloride; Norfloxacin
Possible Carboplatin side effects in female
Reported by a pharmacist from United States on 2012-08-20
Patient: female
Reactions: Glossodynia, Unresponsive To Stimuli
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in male
Reported by a physician from Japan on 2012-08-20
Patient: male
Reactions: Pneumonia Aspiration, Haemoptysis
Adverse event resulted in: death, life threatening event
Drug(s) suspected as cause:
Avastin
Indication: Lung Adenocarcinoma
Carboplatin
Indication: Lung Adenocarcinoma
Pemetrexed
Indication: Lung Adenocarcinoma
Possible Carboplatin side effects in male
Reported by a physician from Japan on 2012-08-15
Patient: male, weighing 51.0 kg (112.2 pounds)
Reactions: Haemoptysis, Interstitial Lung Disease, Platelet Count Decreased, Hypertension
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Start date: 2010-11-16
End date: 2010-11-16
Avastin
Start date: 2010-12-16
End date: 2010-12-16
Avastin
Start date: 2010-10-14
End date: 2010-10-14
Avastin
Indication: Lung Adenocarcinoma Recurrent
Start date: 2010-08-17
End date: 2010-08-17
Avastin
Start date: 2010-09-14
End date: 2010-09-14
Carboplatin
Start date: 2010-09-14
End date: 2010-09-14
Carboplatin
Start date: 2010-12-16
End date: 2010-12-16
Carboplatin
Start date: 2010-11-16
End date: 2010-11-16
Carboplatin
Indication: Lung Adenocarcinoma Recurrent
Start date: 2010-08-17
End date: 2010-08-17
Carboplatin
Start date: 2010-10-14
End date: 2010-10-14
Paclitaxel
Start date: 2010-09-14
End date: 2010-09-14
Paclitaxel
Indication: Lung Adenocarcinoma Recurrent
Start date: 2010-08-17
End date: 2010-08-17
Paclitaxel
Start date: 2010-10-14
End date: 2010-10-14
Paclitaxel
Start date: 2010-12-16
End date: 2010-12-16
Paclitaxel
Start date: 2010-11-16
End date: 2010-11-16
Possible Carboplatin side effects in female
Reported by a physician from United States on 2012-08-15
Patient: female, weighing 57.6 kg (126.7 pounds)
Reactions: Abdominal Pain, Diarrhoea, Disseminated Intravascular Coagulation, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: permanently discontinued
End date: 2012-05-25
Carboplatin
Dosage: temporarily discontinued
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Docetaxel
Dosage: permanently discontinued
End date: 2012-05-25
Docetaxel
Dosage: permanently discontinued
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-04
Herceptin
Dosage: permanently discontinued
End date: 2012-05-25
Herceptin
Dosage: maintanance dose, temporarily interrupted
End date: 2012-05-04
Herceptin
Dosage: loading dose, permanently discontinued
Indication: Breast Cancer
Start date: 2012-04-13
Pertuzumab
Dosage: loading dose
Indication: Breast Cancer
Start date: 2012-04-13
End date: 2012-05-25
Other drugs received by patient: Clindamycin; Lovaza; Tylenol; Zofran
Possible Carboplatin side effects in
Reported by a consumer/non-health professional from Singapore on 2012-08-13
Patient:
Reactions: Myalgia, Incorrect Route of Drug Administration, Rhabdomyolysis, Tumour Lysis Syndrome, Demyelination
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Etoposide
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Ifosfamide
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Rituximab
Dosage: unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Velcade
Dosage: unk mg/m2, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2012-06-21
End date: 2012-07-26
Velcade
Dosage: unk
Start date: 2012-07-31
Other drugs received by patient: Methotrexate Sodium; Acyclovir; Pentamidine; Omeprazole; Lamivudine
Possible Carboplatin side effects in male
Reported by a physician from Japan on 2012-08-13
Patient: male, weighing 65.0 kg (143.0 pounds)
Reactions: Intestinal Ischaemia, Disseminated Intravascular Coagulation, Shock
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Avastin
Indication: Lung Adenocarcinoma Metastatic
Start date: 2012-06-19
End date: 2012-07-18
Carboplatin
Indication: Lung Adenocarcinoma Metastatic
Start date: 2012-06-19
End date: 2012-07-18
Paclitaxel
Indication: Lung Adenocarcinoma Metastatic
Start date: 2012-06-19
End date: 2012-07-18
Other drugs received by patient: Decadron Phosphate; Aloxi
Possible Carboplatin side effects in 54 year old male
Reported by a consumer/non-health professional from United States on 2012-08-10
Patient: 54 year old male, weighing 70.0 kg (154.0 pounds)
Reactions: Hypotension, Asthenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Dosage: most recent dose on 1aug12
Start date: 2012-07-30
Paclitaxel
Dosage: most recent dose on 1aug12
Start date: 2012-07-30
Possible Carboplatin side effects in 61 year old female
Reported by a physician from United States on 2012-08-07
Patient: 61 year old female, weighing 71.2 kg (156.6 pounds)
Reactions: Vomiting, Pruritus, Nausea, Stridor, Unresponsive To Stimuli, Hypotension, Tachycardia, Torticollis, Infusion Related Reaction
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Other drugs received by patient: Magnesium Oxide; Zolpidem; Escitalopram
Possible Carboplatin side effects in 59 year old female
Reported by a physician from Germany on 2012-08-06
Patient: 59 year old female, weighing 57.0 kg (125.4 pounds)
Reactions: Syncope, Urinary Incontinence, Cardiovascular Disorder
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Carboplatin
Other drugs received by patient: Clemastine Fumarate; Ranitidine HCL; Granisetron; Paclitaxel-Actavis; Dexamethasone
Possible Carboplatin side effects in
Reported by a consumer/non-health professional from United States on 2012-08-06
Patient:
Reactions: Rhabdomyolysis, Renal Failure Acute
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Amoxicillin
Dosage: 500 mg, tid
Administration route: Oral
Carboplatin
Dosage: 4 in 1 cyclical
Gemcitabine Hydrochloride
Dosage: 4 in 1 cyclical
Omeprazole
Dosage: 20 mg, unk
Administration route: Oral
Zocor
Dosage: 80 mg, qd
Administration route: Oral
Other drugs received by patient: Aspirin; Coracten; Clarithromycin; Atenolol; Granisetron; Chlordiazepoxide; Ciprofloxacin
Possible Carboplatin side effects in female
Reported by a physician from China on 2012-08-06
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Death, Cardiac Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: most recent dose prior to the event: 21/mar/2012, 840 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Carboplatin
Dosage: most recent dose prior to event: 21/mar/2012, 739 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Paclitaxel
Dosage: most recent dose prior to event: 21/mar/2012, 265 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Possible Carboplatin side effects in 75 year old female
Reported by a physician from United States on 2012-08-02
Patient: 75 year old female, weighing 49.7 kg (109.4 pounds)
Reactions: Activated Partial Thromboplastin Time Prolonged, Fatigue, Hypocalcaemia, White Blood Cell Count Decreased, Vomiting, Nausea, Hypotension, Renal Failure Chronic, Hypophosphataemia, Syncope, Respiratory Failure, Embolism, Diarrhoea, Aspartate Aminotransferase Increased, Hypermagnesaemia, Hypoalbuminaemia, Neutrophil Count Decreased, Enterocolitis Infectious
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: over 30-90 minutes on day 1 of cycles 2+. drug withdrawn.
Indication: Ovarian Epithelial Cancer
Start date: 2012-01-31
End date: 2012-02-21
Carboplatin
Dosage: auc=6 iv on day 1 (cycle 1-6)
Indication: Ovarian Epithelial Cancer
Start date: 2012-01-31
Paclitaxel
Dosage: over 3 hours on day 1 (cycles, 1-6).
Indication: Ovarian Epithelial Cancer
Start date: 2012-01-31
Possible Carboplatin side effects in 51 year old female
Reported by a physician from Italy on 2012-07-30
Patient: 51 year old female
Reactions: Swelling Face, Rash Generalised, Feeling Hot, Formication
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in male
Reported by a physician from Japan on 2012-07-27
Patient: male, weighing 48.0 kg (105.6 pounds)
Reactions: White Blood Cell Count Decreased, Pneumonia Aspiration, Vomiting, Pulmonary Embolism, Leukoencephalopathy, Pyrexia, Neutrophil Count Decreased, Decreased Appetite
Adverse event resulted in: death, life threatening event, disablity
Drug(s) suspected as cause:
Alimta
Indication: Lung Adenocarcinoma Recurrent
Start date: 2012-03-13
End date: 2012-03-13
Avastin
Indication: Lung Neoplasm Malignant
Start date: 2012-03-13
End date: 2012-03-13
Carboplatin
Dosage: dosage: 5 auc a day
Indication: Lung Adenocarcinoma Recurrent
Start date: 2012-03-13
End date: 2012-03-13
Methylprednisolone Sodium Succinate
Dosage: dosage is uncertain.
Indication: Leukoencephalopathy
Start date: 2012-04-26
End date: 2012-01-01
Other drugs received by patient: Tannalbin; Panvitan; Flivas; Neuer; Medicon; Urso 250; Eviprostat
Possible Carboplatin side effects in male
Reported by a pharmacist from United States on 2012-07-25
Patient: male, weighing 106.3 kg (233.9 pounds)
Reactions: Chest Pain
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: 180-150mg 4 cycles iv drip
Indication: Head and Neck Cancer
Start date: 2012-03-19
End date: 2012-04-09
Dexamethasone Sodium Phosphate
Dosage: 20mg once w/ chemo iv drip
Indication: Vomiting
Start date: 2012-03-19
End date: 2012-04-25
Other drugs received by patient: Metorpolol Tartrate 300mg; Diphenhydramine 50mg; Rosuvastatin; Isosorbide Dinitrate 90mg; Ondansetron 8MG IV; Cetuximab 580mg; Ranitidine 450mg; Acetaminophen; Lisinopril; Amlodipine Besylate; Levothyroxine NA 0.088mg
Possible Carboplatin side effects in 51 year old female
Reported by a physician from Italy on 2012-07-24
Patient: 51 year old female
Reactions: Swelling Face, Rash Generalised, Feeling Hot, Formication
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Carboplatin
Possible Carboplatin side effects in female
Reported by a physician from China on 2012-07-24
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Death, Cardiac Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: most recent dose prior to the event: 21/mar/2012
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Carboplatin
Dosage: most recent dose prior to event: 21/mar/2012, 739 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Paclitaxel
Dosage: most recent dose prior to event: 21/mar/2012, 265 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Possible Carboplatin side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-24
Patient: 58 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Febrile Neutropenia, Radiation Mucositis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: 1df auc =5, dose redused to auc 3.
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Gemcitabine Hydrochloride
Dosage: last dose on:11jun12 dose redused to:500mg/m2
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Ramucirumab
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Other drugs received by patient: Warfarin Sodium; Levaquin; Roxanol; Neupogen; Zometa; Methadone HCL; Promethazine; Prilosec; Platelets; Ondansetron
Possible Carboplatin side effects in 64 year old female
Reported by a physician from United States on 2012-07-23
Patient: 64 year old female, weighing 102.0 kg (224.4 pounds)
Reactions: Abdominal Pain, Hyponatraemia, Disease Progression, Soft Tissue Infection, Death, Fatigue, Colonic Fistula, Hypermagnesaemia, Hypoalbuminaemia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Ovarian Epithelial Cancer
Start date: 2009-12-03
Carboplatin
Indication: Ovarian Epithelial Cancer
Start date: 2009-12-03
Paclitaxel
Indication: Ovarian Epithelial Cancer
Start date: 2009-12-03
Possible Carboplatin side effects in 66 year old male
Reported by a physician from Japan on 2012-07-20
Patient: 66 year old male
Reactions: Pneumonia, Interstitial Lung Disease
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Adriamycin PFS
Dosage: 40 mg/m2, unk
Start date: 2010-12-22
End date: 2010-12-22
Adriamycin PFS
Dosage: 30 mg/m2, unk
Start date: 2010-10-14
End date: 2010-10-14
Adriamycin PFS
Dosage: 30 mg/m2, unk
Start date: 2010-11-24
End date: 2010-11-24
Adriamycin PFS
Dosage: 30 mg/m2, unk
Start date: 2010-12-29
End date: 2010-12-29
Adriamycin PFS
Dosage: 40 mg/m2, unk
Start date: 2010-11-16
End date: 2010-11-16
Adriamycin PFS
Dosage: 40 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-10-07
Allopurinol
Dosage: 100 mg, 3x/day
Administration route: Oral
Start date: 2011-07-05
End date: 2011-07-19
Allopurinol
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Hyperuricaemia
End date: 2011-01-20
Amlodipine
Dosage: 5 mg, 1x/day
Administration route: Oral
Indication: Hypertension
Start date: 2010-10-08
End date: 2011-02-17
Baraclude
Dosage: 0.5 mg, 1/2day
Administration route: Oral
Indication: Hepatitis B
Start date: 2010-06-29
End date: 2011-07-19
Carboplatin
Dosage: 250 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-26
End date: 2010-12-08
Cefazolin Sodium
Dosage: unk
Administration route: Oral
Indication: Proctitis
Start date: 2010-10-22
End date: 2011-02-17
Cyclophosphamide
Dosage: 350 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-12-22
Cymerin
Dosage: 60 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-14
End date: 2010-12-29
Cytarabine
Dosage: 40 mg, daily
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-11-18
End date: 2010-11-18
Diflucan
Dosage: 100 mg, 1x/day
Administration route: Oral
Indication: Antifungal Prophylaxis
End date: 2011-01-11
Diflucan
Dosage: unk
Start date: 2011-01-19
End date: 2011-01-28
Etoposide
Dosage: 100 mg/m2, 3x/day
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-26
End date: 2010-12-08
Fentanyl
Dosage: unk
Indication: Stomatitis
Start date: 2011-01-02
End date: 2011-01-19
Fildesin
Dosage: 2.4 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-26
End date: 2010-12-08
KW-0761
Dosage: 1 mg/kg, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-08
End date: 2010-12-21
Lansoprazole
Dosage: 15 mg, 1x/day
Administration route: Oral
Start date: 2011-05-26
End date: 2011-07-19
Lansoprazole
Dosage: 15 mg, 1x/day
Administration route: Oral
Indication: Gastrooesophageal Reflux Disease
End date: 2011-02-17
Lipidil
Dosage: 100 df, 1x/day
Administration route: Oral
Indication: Hyperlipidaemia
End date: 2011-01-26
Lyrica
Dosage: 75 mg, 1x/day
Administration route: Oral
Indication: Pain
Start date: 2011-06-29
End date: 2011-07-19
Magmitt
Dosage: unk
Administration route: Oral
Indication: Constipation
Start date: 2011-01-07
End date: 2011-01-10
Meropenem
Dosage: 0.5 g, 2x/day
Indication: Pneumonia
Start date: 2011-01-07
End date: 2011-01-24
Meropenem
Dosage: 1 g, 3x/day
Start date: 2011-07-04
End date: 2011-07-15
Methotrexate Sodium
Dosage: 15 mg, daily
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-11-18
End date: 2010-11-18
Oncovin
Dosage: 1 mg/m2, unk
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-12-22
Pantosin
Dosage: unk
Administration route: Oral
Indication: Constipation
Start date: 2011-01-07
End date: 2011-01-10
Prednisolone
Dosage: 40 mg/m2, unk
Administration route: Oral
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-10-07
End date: 2010-12-29
Prednisolone
Dosage: 10 mg, daily
Indication: Adult T-Cell Lymphoma / Leukaemia
Start date: 2010-11-18
End date: 2010-11-18
Sulfamethoxazole and Trimethoprim
Dosage: 1 df, 1x/day
Administration route: Oral
Start date: 2011-07-15
Sulfamethoxazole and Trimethoprim
Dosage: 1 df, 1x/day
Administration route: Oral
Indication: Antifungal Prophylaxis
End date: 2011-01-28
Vancomycin
Dosage: 0.5 g, 2x/day
Start date: 2011-01-07
End date: 2011-01-17
Zovirax
Dosage: unk
Start date: 2011-06-30
End date: 2011-07-08
Zovirax
Dosage: 200 mg, 1x/day
Administration route: Oral
Indication: Prophylaxis
End date: 2011-01-28
Zovirax
Dosage: 200 mg, 1x/day
Administration route: Oral
Start date: 2011-07-12
End date: 2011-07-19
Other drugs received by patient: Vfend; Targocid; Slow-K; Ciprofloxacin HCL
Possible Carboplatin side effects in female
Reported by a physician from China on 2012-07-18
Patient: female, weighing 54.0 kg (118.8 pounds)
Reactions: Death, Cardiac Failure
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Dosage: most recent dose prior to the event: 21/mar/2012
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Carboplatin
Dosage: most recent dose prior to event: 21/mar/2012, 739 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Paclitaxel
Dosage: most recent dose prior to event: 21/mar/2012, 265 mg
Indication: non-Small Cell Lung Cancer
Start date: 2012-01-05
Possible Carboplatin side effects in 64 year old female
Reported by a physician from United States on 2012-07-18
Patient: 64 year old female, weighing 102.0 kg (224.4 pounds)
Reactions: Abdominal Pain, Hyponatraemia, Disease Progression, Death, Soft Tissue Infection, Fatigue, Colonic Fistula, Hypermagnesaemia, Hypoalbuminaemia
Adverse event resulted in: death, life threatening event, hospitalization
Drug(s) suspected as cause:
Avastin
Indication: Ovarian Epithelial Cancer
Start date: 2009-12-03
Carboplatin
Indication: Ovarian Epithelial Cancer
Start date: 2009-12-03
Paclitaxel
Indication: Ovarian Epithelial Cancer
Start date: 2009-12-03
Possible Carboplatin side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-17
Patient: 58 year old male, weighing 58.0 kg (127.6 pounds)
Reactions: Oropharyngeal Pain, Neutropenia, Radiation Mucositis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: 1df auc =5, dose redused to auc 3.
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Gemcitabine Hydrochloride
Dosage: last dose on:11jun12 dose redused to:500mg/m2
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Ramucirumab
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Other drugs received by patient: Prilosec; Ondansetron; Neupogen; Methadone HCL; Levaquin; Roxanol; Zometa; Promethazine; Warfarin Sodium; Platelets
Possible Carboplatin side effects in male
Reported by a physician from United States on 2012-07-17
Patient: male, weighing 64.7 kg (142.3 pounds)
Reactions: Febrile Neutropenia, Radiation Mucositis
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Carboplatin
Dosage: unk, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
End date: 2012-06-04
Carboplatin
Dosage: 3 df, other
Gemcitabine Hydrochloride
Dosage: 500 mg/m2, other
Gemcitabine Hydrochloride
Dosage: 1000 mg/m2, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
End date: 2012-06-11
Ramucirumab (1121b) (Ly3009806)
Dosage: 10 mg/kg, other
Indication: non-Small Cell Lung Cancer
Start date: 2012-06-04
Other drugs received by patient: Hydrocodone; Roxanol; Ondansetron; Promethazine; Zometa; Levaquin; Methadon HCL TAB; Prilosec; Warfarin Sodium; Neupogen; Platelets; Promethazine
Page 1 Next >>
|
